Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Dyne Therapeutics Inc (NASDAQ: DYN) was $46.12 for the day, up 1.61% from the previous closing price of $45.39. In other words, the price has increased by $1.61 from its previous closing price. On the day, 1.58 million shares were traded. DYN stock price reached its highest trading level at $46.74 during the session, while it also had its lowest trading level at $44.51.
Ratios:
Our analysis of DYN’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 26.63 and its Current Ratio is at 26.63. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.03.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Chardan Capital Markets on May 21, 2024, Reiterated its Buy rating but revised its target price to $42 from $31 previously.
On April 30, 2024, Morgan Stanley started tracking the stock assigning a Overweight rating and target price of $40.
On February 20, 2024, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $36.H.C. Wainwright initiated its Buy rating on February 20, 2024, with a $36 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Aug 19 ’24 when Farwell Wildon bought 2,321 shares for $45.12 per share.
Scalzo Richard William bought 2,752 shares of DYN for $124,163 on Aug 19 ’24. On Jun 11 ’24, another insider, Beskrovnaya Oxana, who serves as the Officer of the company, bought 2,636 shares for $45.12 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DYN now has a Market Capitalization of 4630494208 and an Enterprise Value of 3877363712.
Stock Price History:
Over the past 52 weeks, DYN has reached a high of $46.39, while it has fallen to a 52-week low of $6.40. The 50-Day Moving Average of the stock is 18.78%, while the 200-Day Moving Average is calculated to be 81.93%.
Shares Statistics:
DYN traded an average of 1.28M shares per day over the past three months and 1033190 shares per day over the past ten days. A total of 100.40M shares are outstanding, with a floating share count of 72.70M. Insiders hold about 27.59% of the company’s shares, while institutions hold 84.33% stake in the company. Shares short for DYN as of 1722384000 were 9881196 with a Short Ratio of 7.72, compared to 1719532800 on 9076068. Therefore, it implies a Short% of Shares Outstanding of 9881196 and a Short% of Float of 11.85.
